Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
03/2014
03/13/2014WO2014037313A1 Use of substituted benzodiazepinones and benzazepinones or the salts thereof as active substances against abiotic plant stress
03/13/2014WO2014036823A1 Novel preparation method of antithrombosis medicine
03/13/2014WO2014015167A3 5,5-heteroaromatic anti-infective compounds
03/13/2014US20140073791 Novel salts of sitagliptin, process for the preparation and pharmaceutical composition thereof
03/13/2014US20140073657 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
03/13/2014US20140073653 Modulators of cystic fibrosis transmembrane conductance regulator
03/13/2014US20140073645 Treatment of Solid Tumours
03/13/2014US20140073641 1-heterocyclyl-1,5-dihydro-pyrazolo[3,4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
03/13/2014US20140073640 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
03/13/2014US20140073638 Ethynyl compounds useful for treatment of cns disorder
03/13/2014US20140073633 Inhibitors of the shiga toxins trafficking through the retrograde pathway
03/13/2014US20140073632 Treating protein folding disorders with small molecule cftr correctors
03/13/2014US20140073631 Antiviral and antimicrobial compounds
03/13/2014US20140073630 Pharmaceutical compositions for the treatment of cancer and other diseases or disorders
03/13/2014US20140073626 Azaindole derivatives as tyrosine kinase inhibitors
03/13/2014US20140073624 Biaryl Heterocyclic Compounds and Methods of Making and Using the Same
03/13/2014US20140073623 Tricyclic Sulfonamide Compounds and Methods of Making and Using Same
03/13/2014US20140073622 Imidazole carbonyl compound
03/13/2014US20140072554 Pyrazolo[1,5-a]pyrimidines for antiviral treatment
03/13/2014US20140072529 Substituted 2,3-dihydroimidazo[1,2-c]quinazoline salts
03/12/2014EP2705753A1 2-Phenyl-imidazolotriazinone compounds as PDE5 inhibitors
03/12/2014EP2705181A1 Combination pharmaceutical compositions and uses thereof
03/12/2014EP2705049A1 Hepatitis c virus inhibitors
03/12/2014EP2705039A2 Bromodomain inhibitors and uses thereof
03/12/2014EP2705038A1 Substituted imidazopyridines and the use thereof
03/12/2014EP2705037A1 Substituted imidazopyridines and imidazopyridazines and the use thereof
03/12/2014EP2705036A1 Tricyclic sulfonamide compounds and methods of making and using same
03/12/2014EP2705029A1 Novel compounds as modulators of protein kinases
03/12/2014EP2705026A1 Process for the production of sitagliptin
03/12/2014EP2705013A1 Pentylenetetrazole derivatives
03/12/2014CN103635473A Dispiropyrrolidine derivative
03/12/2014CN103635446A Pentylenetetrazole derivatives
03/12/2014CN103626783A Dicyclic fused heterocyclic compounds, and applications and pharmaceutical compositions thereof
03/12/2014CN103626781A Targeted anti-cancer molecule gefitinib phthalocyanine conjugate, and preparation and application thereof
03/12/2014CN103626780A Preparation equipment of chlorophyll metal salt
03/12/2014CN103626779A Method for extracting chlorophyll from luffa leaf
03/12/2014CN103626778A Method for preparing chlorophyll metallic sodium salt by taking silkworm feces as raw material
03/12/2014CN103626777A PLK inhibitor salts
03/12/2014CN103626776A Pyrazolo[1,5-alpha] pyrimidine nitrogen mustard derivatives, preparation methods of pyrazolo[1,5-alpha] pyrimidine nitrogen mustard derivatives, and application of pyrazolo[1,5-alpha] pyrimidine nitrogen mustard derivatives in oncotherapy
03/12/2014CN103626775A DPP-4 inhibitor with diazine structure
03/12/2014CN103626774A Preparation method of Ibrutinib
03/12/2014CN103626773A Salt of vasicine derivative
03/12/2014CN103626772A Synthetic method for temozolomide and intermediate
03/12/2014CN103626767A Azaindole with regionselectivity and synthetic method thereof
03/12/2014CN103626743A Novel intermediate of ticagrelor and preparation method thereof
03/12/2014CN102659793B Phthalocyanine silicon modified by amino ethyl groups and phenoxy groups as well as preparation method and application thereof
03/12/2014CN102432615B Compound used as dye sensitizing agent of solar cell and preparation method thereof
03/12/2014CN102341396B Material for use in phosphorescent device and organic electroluminescent device using same
03/12/2014CN102326273B Organic electroluminescent element
03/12/2014CN101970443B RNA-selective hybridization reagent and utilization of same
03/12/2014CN101827850B Novel compounds of reverse turn mimetics and use thereof (2)
03/12/2014CN101801973B 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and use as met inhibitors
03/12/2014CN101679191B Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
03/11/2014US8669359 Electrically conducting porphyrin and porphyrin-fullerene electropolymers
03/11/2014US8669289 Methods and compositions relating to hematologic malignancies
03/11/2014US8669251 8-fluorophthalazin-1(2H)-one compounds
03/11/2014US8669081 Compositions useful as inhibitors of protein kinases
03/11/2014CA2784180C Seven-membered ring compound and pharmaceutical use therefor
03/06/2014WO2014034626A1 CRYSTAL OF N-[2-({2-[(2S)-2-CYANOPYRROLIDIN-1-YL]-2- OXOETHYL}AMINO)-2-METHYLPROPYL]-2-METHYLPYRAZOLO[1,5-a]PYRIMIDINE-6-CARBOXAMIDE
03/06/2014WO2013190510A3 NOVEL 2,3-DIHYDRO-1H-IMIDAZO{1,2-a}PYRIMIDIN-5-ONE and this1,2,3,4-TETRAHYDROPYRIMIDO{1,2-a}PYRIMIDIN-6-ONE DERIVATIVES COMPRISING A SUBSTITUTED MORPHOLINE, PREPARATION THEREOF AND PHARMACEUTICAL USE THEREOF
03/06/2014WO2013063468A8 Amino acid derivates functionalized on the n- terminal capable of forming drug incapsulating microspheres
03/06/2014WO2012138981A3 New intermediates and processes for preparing ticagrelor
03/06/2014US20140066629 Process for the preparation of aromatic azole compounds
03/06/2014US20140066625 Fused Imidazole Derivatives Useful as IDO Inhibitors
03/06/2014US20140066622 Imidazo[5,1-f][1,2,4]Triazines For The Treatment of Neurological Disorders
03/06/2014US20140066466 Necroptosis Inhibitors and Methods of Use Therefor
03/06/2014US20140066463 Solid forms of pemetrexed
03/06/2014US20140066436 Pyrimidine derivatives as protein kinase inhibitors
03/06/2014US20140066435 Pyrrolobenzodiazepines used to treat proliferative diseases
03/06/2014US20140066434 Methods and Compositions for Treating Parkinson's Disease
03/06/2014US20140066433 Fused heterocyclic derivatives as s1p modulators
03/06/2014US20140066429 Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp) for use in treatment of diseases associated with a pten deficiency
03/06/2014US20140066428 6,7,8,9-Tetrahydro-5H-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them
03/06/2014US20140066426 Fluoromethyl-substituted pyrrole carboxamides
03/06/2014US20140066412 Heteroaryl substituted urea modulators of fatty acid amide hydrolase
03/06/2014US20140066369 Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
03/05/2014EP2703403A1 Imidazole derivative
03/05/2014EP2702063A1 Bicyclic pyridazine compounds as pim inhibitors
03/05/2014EP2702062A1 Salt of an inhibitor of phosphodiesterase 10 enzyme
03/05/2014EP2702061A1 Pyrrolotriazinone derivatives as pi3k inhibitors
03/05/2014EP2702056A1 Derivatives of n- [(1h-pyrazol-1-yl) aryl]- 1h - indole or 1h - indazole - 3 - carboxamide, their preparation and their use as p2y12 antagonists
03/05/2014EP2702050A1 Pyrazolidin-3-one derivatives
03/05/2014EP2701510A1 Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
03/05/2014CN1882590B Fused heterocyclic compounds as serotonin receptor modulators
03/05/2014CN103620864A Photoelectric conversion element, photoelectrochemical cell, and dyes for use therein
03/05/2014CN103620808A Organic electroluminescent element
03/05/2014CN103620806A Light emitting element material and light emitting element
03/05/2014CN103619846A 1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivatives
03/05/2014CN103619845A Fluoroalkyl-substituted pyrazolopyridines and use thereof
03/05/2014CN103619844A N-substituted hetero-bicyclic compounds and derivatives for combating animal pests
03/05/2014CN103619841A Heteroaryl compounds and methods of use thereof
03/05/2014CN103619834A Derivatives of N-[(1H-pyrazol-1-yl)aryl]-1H-indole or 1H-indazole-3-carboxamide, their preparation and their use as P2Y12 antagonists
03/05/2014CN103613598A Method for preparing polymorphism photosensitivity TiOPc nano particle and application thereof in organic photoconductor
03/05/2014CN103613597A Preparation process of sildenafil citrate
03/05/2014CN103613592A Synthesis method of aromatic ring or aromatic heterocyclic ring-fused amide
03/05/2014CN102498091B Glycine compound
03/05/2014CN102026999B Azetidine and cyclobutane derivatives as JAK inhibitors
03/05/2014CN101495464B Prokineticin 1 receptor antagonists
03/04/2014US8664396 Photoluminescent metal complexes for protein staining
03/04/2014US8664382 Antibacterial compositions comprising metal phthalocyanine analogues
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 573